MAXWELL
Maxwell Biotech Group (MBG) is a development partner and financial resource for biotechnology companies. MBG provides investment capital and access to an established infrastructure for conducting high-quality clinical trials in Russia, and helps enable the rapid and cost-effective achievement of clinical objectives. Their unique business model can add value to Their partners’ pipelines and provide a commercialization path to one of the most lucrative emerging markets. MBG relies on an experienced international team of managers and financial and industry experts, with representatives in Boston (USA).
MAXWELL
Social Links:
Industry:
Biotechnology
Founded:
2009-01-01
Address:
Moscow, Moscow City, Russian Federation
Country:
Russian Federation
Website Url:
http://www.maxwellbio.com
Total Employee:
1+
Status:
Active
Contact:
+7 (495) 726-52-53
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Nginx Cloudflare DNS GlobalSign WordPress 5.4 AlphaSSL
Official Site Inspections
http://www.maxwellbio.com
- Host name: server41.hosting.reg.ru
- IP address: 37.140.192.24
- Location: Russia
- Latitude: 55.7386
- Longitude: 37.6068
- Timezone: Europe/Moscow
More informations about "Maxwell"
Maxwell Biosciences — a Synthetic Immune System: Biodefense ...
Founded in 2016, Maxwell is a preclinical stage biotechnology company targeting viruses, bacteria, fungi, and biofilm formations, including those that cause many currently untreatable …See details»
About - Maxwell Biosciences
Founded in 2016, Maxwell Biosciences is a preclinical stage drug platform company actively developing an entirely new CLAROMER® biotechnology platform which creates low molecular weight compounds which mimic …See details»
Board Members, Inventors and Advisors - Maxwell …
Mr. McClure is an engineer with over 20 years of experience as a CEO, and 10 years of experience as a corporate board director. He is a multi-patent inventor including antiviral applications of Maxwell’s platform, and human gene …See details»
Maxwell Biosciences - Crunchbase Company Profile
Maxwell Biosciences is a preclinical-stage drug platform company actively developing an entirely new CLAROMER biotechnology platform that creates low-molecular-weight compounds that mimic peptides and are functionally distinct …See details»
Maxwell Biosciences Company Profile 2024: Valuation, Funding ...
Operator of a drug platform company intended to create biomimetic therapeutics and synthetic compounds that mimic and improve upon biomolecules.See details»
Maxwell Biosciences - LinkedIn
Maxwell's first-in-class CLAROMERâ„¢ brand drug discovery platform mimics natural human immune system antimicrobial and antiviral peptides.See details»
MaxWell Biosystems - Crunchbase Company Profile & Funding
MaxWell Biosystems is located in Basel, Basel-Stadt, Switzerland. Who invested in MaxWell Biosystems? MaxWell Biosystems has 4 investors including Technology Fund and Sensirion. …See details»
Maxwell - Crunchbase Company Profile & Funding
Maxwell Biotech Group (MBG) is a development partner and financial resource for biotechnology companies. MBG provides investment capital and access to an established infrastructure for …See details»
Maxwell Biosciences Raises $10.8 Million in …
Mar 10, 2022 · Maxwell, which develops synthetic, low molecular weight drug candidates – CLAROMERS ® – designed to serve as therapeutics against rapidly evolving, widespread viruses, today announced that it has closed an …See details»
MaxWell Biosystems - LinkedIn
Founded in September 2016 as an ETH Zürich spin-off, MaxWell Biosystems is a technology leader providing instrumentation and solutions to boost scientific research and development in...See details»
CBC News Network's Marianne Dimain speaks to an international ...
5 days ago · Get the latest on CBCNews.ca, the CBC News App, and CBC News Network for breaking news and analysis.See details»
MaxWell Biosystems AG - Venturelab
Jan 9, 2016 · MaxWell Biosystems is a global leader providing advanced high-resolution functional cell imaging platforms to facilitate detailed investigation of cells. MaxOne (single …See details»
Maxwell Biosciences Announces the CLAROMER - Business Wire
May 18, 2021 · Maxwell’s CLAROMERâ„¢ brand anti-infectives platform has successfully demonstrated excellent preclinical potency in a recent peer-reviewed publication that shows …See details»
Imagine One Drug for Any Infection - Maxwell Biosciences
Maxwell's Claromers are like a synthetic immune system in that Claromers are small molecules that we make in a lab that mimic the functions of the human body's own antimicrobial peptides. …See details»
Leadership Development & Career Development | Maxwell …
Transform your organization by growing leaders at every level. Earn a living helping others lead. Make the world a better place. Grounded in the values-based leadership principles of one of …See details»
how to REMOVE an Organization from a personal account
19 hours ago · As for the organizational residual issues, I will continue to share the following information with you: Typically, our individual accounts do not have access to delete …See details»
Maxwell Biosciences Raises $10.8 Million in ... - Business Wire
Mar 10, 2022 · Maxwell, which develops synthetic, low molecular weight drug candidates – CLAROMERS â„¢ – designed to serve as therapeutics against rapidly evolving, widespread …See details»
U.S. Investigating Political Action Committee Tied to Mayor Adams
2 days ago · Prosecutors and the F.B.I. are examining an organization founded by the Rev. Alfred Cockfield II, according to people with knowledge of the matter. By William K. Rashbaum Dana …See details»
Maxwell Biosciences Names Two Biotech Leaders to Its Board of …
Nov 7, 2022 · Maxwell Biosciences (“Maxwell"), a preclinical drug platform company focused on the development of first-in-class, synthetic small molecules that mimic natural peptides, today …See details»
Anna Maxwell Martin - Wikipedia
Anna Charlotte Martin was born in Beverley on 10 May 1977 to Rosalind (née Youngson) and Ivan Martin. [2] [3] Her father was managing director of a pharmaceutical company and her …See details»